Cargando…

Biology of primary breast cancer in older women beyond routine biomarkers

PURPOSE: There are numerous biomarkers which may have potential predictive and prognostic significance in breast cancer. This is extremely important in older adults, who may opt for less aggressive therapy. This work outlines the literature on biological assessment outside of standard biomarkers (de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parks, R. M., Alfarsi, L. H., Green, A. R., Cheung, K. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354915/ https://www.ncbi.nlm.nih.gov/pubmed/34165702 http://dx.doi.org/10.1007/s12282-021-01266-5

Ejemplares similares

Biology of Oestrogen-Receptor Positive Primary Breast Cancer in Older Women with Utilisation of Core Needle Biopsy Samples and Correlation with Clinical Outcome
por: Parks, Ruth M., et al.
Publicado: (2020)

Impact of COVID-19 on Older Women Presenting with Breast Cancer
por: Suen, D., et al.
Publicado: (2021)

Oncoplastic breast surgery in older women with primary breast cancer: systematic review
por: Chia, Zoe, et al.
Publicado: (2023)

Immediate breast reconstruction uptake in older women with primary breast cancer: systematic review
por: Lee, Rachel Xue Ning, et al.
Publicado: (2022)

Biological Characteristics and Clinical Outcome of Triple Negative Primary Breast Cancer in Older Women – Comparison with Their Younger Counterparts
por: Syed, Binafsha M., et al.
Publicado: (2014)

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer
por: Masisi, Brendah K., et al.
Publicado: (2021)

Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome
por: Syed, Binafsha Manzoor, et al.
Publicado: (2017)

Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts
por: Syed, B M, et al.
Publicado: (2013)

Correction: Oestrogen receptor negative early operable primary breast cancer in older women—Biological characteristics and long-term clinical outcome
por: Syed, Binafsha Manzoor, et al.
Publicado: (2018)

The Association Between Medication Use in Older Women with Early-Stage Operable Primary Breast Cancer and Decision Regarding Primary Treatment
por: Tse, Natalie, et al.
Publicado: (2023)

The Potential Use of Tumour-Based Prognostic and Predictive Tools in Older Women with Primary Breast Cancer: A Narrative Review
por: Gordon-Craig, Sophie, et al.
Publicado: (2020)

Comprehensive geriatric assessment for older women with early breast cancer – a systematic review of literature
por: Parks, Ruth M, et al.
Publicado: (2012)

Primary Endocrine Therapy in Older Women with Breast Cancer
por: Pepping, R. M. C., et al.
Publicado: (2017)

Comprehensive Geriatric Assessment for Older Women with Early-Stage (Non-Metastatic) Breast Cancer—An Updated Systematic Review of the Literature
por: Reid-Agboola, Chantae, et al.
Publicado: (2023)

Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer
por: Alfarsi, Lutfi H., et al.
Publicado: (2020)

Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray
por: Parks, R. M., et al.
Publicado: (2020)

Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre
por: Syed, B M, et al.
Publicado: (2011)

Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age
por: Johnston, Simon J., et al.
Publicado: (2020)

Liver Kinase B1—A Potential Therapeutic Target in Hormone-Sensitive Breast Cancer in Older Women
por: Syed, Binafsha Manzoor, et al.
Publicado: (2019)

Promoting early presentation of breast cancer in older women: sustained effect of an intervention to promote breast cancer awareness in routine clinical practice
por: Dodd, Rachael H., et al.
Publicado: (2017)

Promoting Early Presentation of Breast Cancer in Older Women: Implementing an Evidence-Based Intervention in Routine Clinical Practice
por: Forbes, Lindsay J. L., et al.
Publicado: (2012)

Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer
por: Ansari, Rokaya El, et al.
Publicado: (2019)

PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer
por: Alfarsi, Lutfi H., et al.
Publicado: (2020)

Does Breast Cancer Surgery Impact Functional Status and Independence in Older Patients? A Narrative Review
por: Chia, Zoe, et al.
Publicado: (2021)

Systematic review of the evidence sources applied to cost-effectiveness analyses for older women with primary breast cancer
por: Wang, Yubo, et al.
Publicado: (2022)

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers
por: Rantalainen, Mattias, et al.
Publicado: (2016)

Routine immunisation programmes in southeast Asia: beyond the routine
por: The Lancet Regional Health – Southeast Asia
Publicado: (2023)

A Continuing Mission to Optimize the Care of Older Women with Breast Cancer
por: Cheung, Kwok-Leung
Publicado: (2017)

Beyond the Routine Influenza Surveillance
por: Choi, Sang-Ho
Publicado: (2016)

The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
por: El Ansari, Rokaya, et al.
Publicado: (2020)

Bridging the age gap in breast cancer: impact of omission of breast cancer surgery in older women with oestrogen receptor-positive early breast cancer on quality-of-life outcomes
por: Morgan, J L, et al.
Publicado: (2021)

Perspectives of older women with early breast cancer on telemedicine during post-primary treatment
por: Buse, Caroline R., et al.
Publicado: (2022)

Breast cancer awareness among older women
por: Linsell, L, et al.
Publicado: (2008)

Far Beyond the Usual Biomarkers in Breast Cancer: A Review
por: dos Anjos Pultz, Brunna, et al.
Publicado: (2014)

Liquid-based biomarkers in breast cancer: looking beyond the blood
por: Shuai, You, et al.
Publicado: (2023)

Bridging the Age Gap in breast cancer: Impact of chemotherapy on quality of life in older women with early breast cancer
por: Battisti, Nicolò Matteo Luca, et al.
Publicado: (2021)

SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer
por: Alfarsi, Lutfi H., et al.
Publicado: (2021)

Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer
por: Morgan, Jenna L., et al.
Publicado: (2021)

Genomic Risk Prediction for Breast Cancer in Older Women
por: Lacaze, Paul, et al.
Publicado: (2021)

Routine breast screening for women aged 65–69: results from evaluation of the demonstration sites
por: Moss, S M, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_kcpcb8acqj8toguik8gk4v442h